ASHG 2026 · Tier 2–3 Academic

Institut universitaire de cardiologie et de pneumologie de Québec at ASHG 2026

Name: ASHG 2026 Annual Meeting
Start: 2026-10-20
End: 2026-10-24
Location: Montréal

Québec, Quebec

Institut universitaire de cardiologie et de pneumologie de Québec at ASHG 2026 in Montréal: 5 presentations (4 posters, 1 lightning talk); 2 research groups.

presentations on the program

research groups identified

Reviewers’ Choice abstracts

Explore everyone at ASHG 2026 →

Organization	ASHG 2026 Attendance
Institut universitaire de cardiologie et de pneumologie de Québec Québec, Quebec	4 PhD Students
Mathieu Labpatrickmathieulab.ca Wet + dry lab~6 people Studies cardiovascular disease using chromatin immunoprecipitation, reporter assays and QTL data. Focuses on vascular atheroma and heart-valve fibrocalcification. 38 papers since 2024 › Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression JAMA Cardiology, 2024 Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation Nature Communications, 2024 Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk European Heart Journal, 2024 Source: OpenAlex author A5071026604 Funded by Canadian Institutes of Health Research (CIHR), Fonds de recherche du Québec (FRQS) +1 more › Canadian Institutes of Health Research (CIHR), Molecular and Genetic Epidemiology to Understand Mitral Valve Prolapse · active Canada's federal health-research funder, the equivalent of the NIH. “[name] receives $1,025,100 over 5 years for his project Molecular and Genetic Epidemiology to Understand Mitral Valve Prolapse.” Fonds de recherche du Québec (FRQS), Fellowship and research grant · 2024-2025 “awarded a fellowship and a research grant from the Fonds de recherche du Québec (FRQS) 2024-2025” Fondation IUCPQ, Jean-G.-Dumesnil scholarship “one-year $16,000 Jean-G.-Dumesnil scholarship, awarded by the Direction de la recherche universitaire in collaboration with the Fondation IUCPQ” Source: lab pages 11 platforms and techniques › Works with DNA-binding assays, Reporter assays, Chromatin immunoprecipitation, Single-cell RNA-sequencing, Single-nucleus RNA-sequencing Techniques Functional genomics, Machine-learning algorithms, Mendelian randomization, Phenome-wide association analyses, Primary culture of human cardiac cells, 3D genome organization assays Source: lab pages Currently hiring › “Doctoral/post-doctoral position: The project involves both bioinformatics and molecular biology analyses.” Source: lab positions page	Talk Wed Oct 21 2:15 pm Single-cell CRISPRi screens identify targets and gene programs promoting heart valve fibrosis Genetic Variation: From Catalogs to Consequences Collaborators: Université Laval DifferentiationRegulation of transcriptionGenome editing/CRISPRSingle-cell Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Single-cell CRISPRi screens identify targets and gene programs promoting heart valve fibrosis Epigenomics Collaborators: Université Laval DifferentiationGenome editing/CRISPRNon-coding RNARegulation of transcription
Arsenault Labresearchgate.net/profile/lab/Benoit-Arsenault-Lab Dry lab~8 people Studies cardiometabolic biomarkers using molecular epidemiology, genomics, proteomics and metabolomics. Targets obesity, fatty liver and valve disease prevention. 46 papers since 2024 › Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression JAMA Cardiology, 2024 Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation Nature Communications, 2024 Mendelian Randomization Applied to Neurology Neurology, 2024 Source: OpenAlex author A5070728487 Funded by Fonds de recherche du Québec - Santé, Instituts de recherche en santé du Canada +4 more › Université Laval - Fonds internes; Fonds de recherche du Québec - Santé, Réseaux thématiques de recherche · 2024-2032 “Réseau thématique de recherche FRQS en santé cardiométabolique, diabète et obésité (CMDO U. Laval 2024-2032)” Instituts de recherche en santé du Canada, Subvention Projet · 2025-2029 “Subvention Projet; Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada; Du 1 avril 2025 au 31 mars 2029” Instituts de recherche en santé du Canada, Subvention Projet · 2024-2029 “Subvention Projet; Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada; Du 1 avril 2024 au 31 mars 2029” +3 more on the lab page Source: lab pages 5 platforms and techniques › Techniques Molecular epidemiology, Mendelian randomization, Pharmacogenomics, Transcriptome-wide association studies, Proteome-wide association studies Source: lab pages No openings posted	Poster Wed Oct 21 2:30 pm An integrated proteogenomic investigation of the human liver uncovers molecular drivers of steatotic liver disease Molecular Effects of Genetic Variation Collaborators: Université Laval Multi-omicsMendelian randomizationProteomicsMetabolic disorder
2 more presenters — research group not yet identified

Meeting Institut universitaire de cardiologie et de pneumologie de Québec in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction